Dan Zandberg
Clinical trials sponsored by Dan Zandberg, explained in plain language.
-
Could diabetes pills boost cancer immunotherapy?
Disease control Recruiting nowThis phase 2 trial is testing whether adding common diabetes drugs (metformin or rosiglitazone) to standard immunotherapy (nivolumab or pembrolizumab) can improve treatment for several advanced solid tumors, including melanoma, lung cancer, and liver cancer. About 72 participants…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could changing when chemo is given boost immunotherapy for head and neck cancer?
Disease control Recruiting nowThis phase 2 trial is testing a new way of giving chemotherapy along with the immunotherapy drug pembrolizumab (Keytruda) for people with advanced head and neck cancer that has come back or spread. The idea is that giving chemo in short, spaced-out pulses after immunotherapy migh…
Phase: PHASE2 • Sponsor: Dan Zandberg • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC